Is WPDPF or BTI a better dividend investment in 2026?

WPDPF currently yields 6666666.67% with a 5% 5-year dividend growth rate. BTI yields 5.40% with 5% growth. The better choice depends on your goal: WPDPF offers higher current income.

What is the dividend yield difference between WPDPF and BTI?

WPDPF has a forward dividend yield of 6666666.67% ($2.00/share annually). BTI yields 5.40% ($3.15/share annually). The yield gap is 6666661.27 percentage points.

Home › Compare › WPDPF vs BTI

WPDPF vs BTI: Dividend Comparison 2026

WPDPF yields 6666666.67% · BTI yields 5.40%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 WPDPF wins by $8.25873857526507e+44M in total portfolio value

INVESTMENT

TIME HORIZON10 years

WPDPF

● Live price

6666666.67%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8.25873857526507e+44M

Annual income

$825,849,488,962,360,000,000,000,000,000,000,000,000,000,000,000,000.00

Full WPDPF calculator →

BTI

● Live price

5.40%

Share price

$58.26

Annual div

$3.15

5Y div CAGR

11.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$37.8K

Annual income

$2,802.29

Full BTI calculator →

Portfolio growth — WPDPF vs BTI

📍 WPDPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	WPDPF	BTI
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, WPDPF + BTI cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

WPDPF pays

BTI pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WPDPF

Annual income on $10K today (after 15% tax)

$566,666,666.67/yr

After 10yr DRIP, annual income (after tax)

$701,972,065,618,006,100,000,000,000,000,000,000,000,000,000,000,000.00/yr

BTI

Annual income on $10K today (after 15% tax)

$459.05/yr

After 10yr DRIP, annual income (after tax)

$2,381.95/yr

At 15% tax rate, WPDPF beats the other by $701,972,065,618,006,100,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WPDPF + BTI for your $10,000?

WPDPF: 50%BTI: 50%

100% BTI50/50100% WPDPF

Portfolio after 10yr

$4.129369287632535e+44M

Annual income

$412,924,744,481,180,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

100.00%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

WPDPF

No analyst data

Altman Z

-107.3

Piotroski

0/9

BTI

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$40.00

-31.3% upside vs current

Range: $40.00 — $40.00

Altman Z

2.1

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WPDPF buys

BTI buys

No recent congressional trades found for WPDPF or BTI in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricWPDPFBTI

Forward yield	6666666.67% ✓	5.40%
Annual dividend / share	$2.00	$3.15 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	11.3% ✓
Portfolio after 10y	$8.25873857526507e+44M	$37.8K ✓
Annual income after 10y	$825,849,488,962,360,000,000,000,000,000,000,000,000,000,000,000,000.00 ✓	$2,802.29
Total dividends collected	$8.258722632802889e+44M	$14.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples

Year-by-year: WPDPF vs BTI ($10,000, DRIP)

Year	WPDPF Portfolio	WPDPF Income/yr	BTI Portfolio	BTI Income/yr	Gap
1← crossover	$666,677,367	$666,666,666.67	$11,301	$601.08	+$666.67M → WPDPF
2	$41,538,243,978,220	$41,537,530,633,437.17	$12,799	$706.58	+$41538243.97M → WPDPF
3	$2,418,785,178,923,619,000	$2,418,740,733,002,562,000.00	$14,527	$832.38	+$2418785178923.60M → WPDPF
4	$131,632,535,180,835,430,000,000	$131,629,947,080,693,970,000,000.00	$16,527	$982.75	+$131632535180835424.00M → WPDPF
5	$6,694,929,569,421,761,000,000,000,000	$6,694,788,722,609,116,000,000,000,000.00	$18,846	$1,162.95	+$6.69492956942176e+21M → WPDPF
6	$318,233,313,948,923,370,000,000,000,000,000	$318,226,150,374,284,100,000,000,000,000,000.00	$21,545	$1,379.49	+$3.1823331394892335e+26M → WPDPF
7	$14,137,160,116,927,522,000,000,000,000,000,000,000	$14,136,819,607,281,600,000,000,000,000,000,000,000.00	$24,694	$1,640.41	+$1.4137160116927522e+31M → WPDPF
8	$586,942,647,681,175,100,000,000,000,000,000,000,000,000	$586,927,520,919,850,000,000,000,000,000,000,000,000,000.00	$28,378	$1,955.69	+$5.8694264768117504e+35M → WPDPF
9	$22,774,359,015,829,920,000,000,000,000,000,000,000,000,000,000	$22,773,730,987,196,898,000,000,000,000,000,000,000,000,000,000.00	$32,702	$2,337.79	+$2.277435901582992e+40M → WPDPF
10	$825,873,857,526,507,000,000,000,000,000,000,000,000,000,000,000,000	$825,849,488,962,360,000,000,000,000,000,000,000,000,000,000,000,000.00	$37,794	$2,802.29	+$8.25873857526507e+44M → WPDPF

WPDPF vs BTI: Complete Analysis 2026

WPDPF — Stock

WPD Pharmaceuticals Inc. engages in the research and development of medicinal products in the fields of oncology and infectious diseases. Its drug development pipeline includes WPD101 to treat brain cancers, including glioblastoma that is in the pre-clinical trial; WPD102 to treat Uval Melanoma, which is in the pre-clinical trial; Berubicin for the treatment of glioblastoma that us in phase 1 clinical trial; and WP1066 to treat central nervous system tumors, pancreatic cancer, and ocular tumors, which is in phase 1 clinical trial. The company's drug development pipeline also includes WP1732 for the treatment of pancreatic cancer; WP1220 to treat cutaneous T-cell lymphoma; WPD103 for the treatment of glioblastoma multiforme that is in the pre-clinical trial; and Annamycin to treat acute myeloid leukemia (AML) and metastasis to lungs, which is in Phase I/II clinical trials in AML. WPD Pharmaceuticals Inc. is headquartered in Vancouver, Canada.

Full WPDPF Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →

📬

Get this WPDPF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WPDPF vs SCHD WPDPF vs JEPI WPDPF vs O WPDPF vs KO WPDPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.